The Global Oculoplastic Surgery Market Size was valued at USD 9.3 Billion in 2023 and is anticipated to reach USD 15.5 Billion by 2032 with a CAGR of 5.9% from 2024 to 2032.

Oculoplastic surgery is a surgical specialty that deals with surgery of the eye and the adjacent structures such as the eyelids, tear drainage system and the orbit. This field is a combination of plastic surgery and ophthalmology, many times, the problems are both cosmetic and medical. Oculoplastic surgeries are performed to correct surgical scars, diseases such as ptosis, or congenital anomalies and to treat functional issues such as a blocked tear duct, or an abnormal position of the eyelid. Also, oculoplastic surgery may be needed for aesthetic reasons, in order to align the eyes or fix problems that are associated with aging.

Usually, oculoplastic operations are performed by ophthalmologists who have received additional training in plastic or reconstructive surgery. There are situations when head and neck surgeons may also perform these operations. It is an operation that aims at not only correcting the patient’s eye function and comfort but also the vision of the eyes. It is a very specific branch of dentistry, which requires both technical and esthetic approaches in order to deliver functional and esthetical results.

Oculoplastic Surgery Market Dynamics

The factors that have fuelled the growth of oculoplastic surgery include a rising awareness of the procedures and an ageing population, which is likely to experience issues such as drooping eyelids, bags under the eyes, or other functional or aesthetic problems involving the eyes. People’s desire to look better in addition to the medical need has played a big part in the increase in the procedures. The fact that there are safer and less invasive surgical procedures which are cheaper due to improvements in technology is also a driver of the market. In addition, with increasing population density around the world, more individuals are benefiting from sophisticated surgical procedures, and the increasing number of qualified plastic surgeons should see this market continue to increase.

The global oculoplastic surgery market is expected to experience a positive impact of the trend in medical tourism. Increased reimbursement policies in developed and developing countries allow patients to go through these procedures. These policies, coupled with the increasing disposable income per capita and increasing trend in acceptance of cosmetic surgeries have created a favourable environment to encourage individuals to seek oculoplastic surgeries. This trend is also supported by the availability of a greater number of treatments, and increased knowledge of the safety and effectiveness of today’s procedures.

Innovative technologies like radiofrequency assisted and laser assisted blepharoplasty are among the other factors that are likely to drive the market growth. Tools such as Rohrer Aesthetics, Inc.’s PIXEL8 PRO laser system are enhancing the surgical application and minimizing risks of complications in eyelid surgery, thus making such surgeries more appealing to both the patient and the surgeon. The availability of advanced lasers and minimally invasive instruments in oculoplastic surgery improves surgical efficiency and widens the range of offered procedures, which is a major factor in the strong growth of the market.

With the increasing ageing population across the world, more people are likely to require oculoplastic surgery because of the facial and eyelid problems that accompany old age. The World Health Organization has projected that by the year 2030, one person in every six people will be 60 years or older, and this group of people will need more medical and aesthetic procedures. The global population of people aged 60 years and above reached 1 billion in 2020, and it is expected to reach 1.4 billion by 2030 – a massive target market for oculoplastic surgery. These demographic changes, together with improvements in surgical procedures and favorable reimbursement conditions, may pave the way for the market’s further growth in the next years.

Global Oculoplastic Surgery Market Segment Analysis

Oculoplastic Surgery Market By Product

·       Reagents & Kits

·       Instruments

o   Clamps

o   Forceps

o   Hooks and Retractors

o   Knife Handles and Blades

o   Needle Holders

o   Scissors

o   Others

·       Equipment

Biological safety testing market is segmented based on the reagents and kits, services, and software in 2023 with the largest share of the Reagents & Kits segment. The growth of this segment can be explained by a higher demand for accurate and efficient testing equipment in biopharmaceutical processes, and the high usage of reagents and kits in biological safety tests like endotoxin tests, sterility tests, and bioburden testing. Another reason that has led to this segment to dominate the market is the fact that reagent and kits are frequently used in laboratories for daily testing and quality assurance..

Oculoplastic Surgery Market By Procedure

·       Eyelid Surgery

·       Facelift

·       Brow Lift/ Forehead Lift

·       Pediatric Oculoplastic Surgery

·       Orbital Surgery

According to the oculoplastic surgery industry analysis, the Eyelid Surgery segment in oculoplastic surgery market is gaining substantial market share in the global market. This is due to increasing needs for cosmetic and reconstructive operations involving the eyes and the eyelids. Blepharoplasty or eyelid surgery is one of the most frequently performed oculoplastic operations which aims to correct ptosis, remove the redundant skin, and treat vision abnormalities resulting from congenital or acquired eyelid abnormalities. Furthermore, the growing incidence of the aging population that requires surgical correction of changes in the eyelids also contributes to the leadership of this segment. The increasing trend for less invasive surgeries and the increasing use of laser technology in the surgery of the eyelids have also propelled the segment.

Oculoplastic Surgery Market By End-Use

·       Hospitals and Clinics

·       Ambulatory Surgical Centers

In terms of end user, the ambulatory surgical centers (ASCs) segment is expected to grow rapidly in the forecast period from 2024 to 2032. This growth can be attributed to reasons such as increased use of minimally invasive surgeries, shorter length of stay, and affordability of surgeries in ASCs. These centers are less costly than hospitals and are most efficient especially for elective surgeries such as oculoplastic surgeries. Also, the increased interest in outpatient procedures and the development of surgical procedures support the decision to develop ASCs. Therefore, the ASCs segment is expected to grow at a higher rate during the forecasting period.

Oculoplastic Surgery Market Regional Analysis

North America is expected to be the largest market for oculoplastic surgery due to factors such as an ageing population, increase in disposable income and growing trend of aesthetic procedures. The desire to spend money on such procedures has increased the number of operations associated with face lifting and other functional procedures. The American Society of Plastic Surgeons reveals that around 23 million cosmetic procedures were conducted in the United States in 2021, which has greatly contributed to the growth of the market in this area. They are supported by high awareness of available procedures and presence of developed healthcare infrastructure which in turn strengthens this market position.

In Europe, the market for oculoplastic surgery is projected to grow steadily as the population of the elderly increases and as more people seek procedures that correct both form and function. European countries have been experiencing growing demand in these surgeries due to the enhancement of awareness of the general population with the benefits of the surgeries which include enhanced appearance and treatment of age-related eye problems. However, the Asia Pacific region is expected to witness the faster growth in the future years. This is due to increased incidence of geriatric population, increased awareness and acceptance of oculoplastic surgery. Furthermore, a greater incidence of oculoplastic problems, including tear drainage anomalies and eyelid abnormalities, in this area has created a demand for reconstructive procedures, which has contributed to market growth.

Oculoplastic Surgery Market Leading Companies

The oculoplastic surgery market players profiled in the report is Bausch + Lomb, Bolton Surgical Ltd, BVI Medical, Carl Zeiss Meditec AG, FCI, Integra LifeSciences Corporation, Matrix Surgical USA, RUMEX International Co., Stryker, and Surgical Holdings.

Oculoplastic Surgery Market Regions